Early COVID-19 Therapy with azithromycin plus nitazoxanide, ivermectin or hydroxychloroquine in Outpatient Settings Significantly Improved COVID-19 outcomes compared to Known outcomes in untreated patients

DOI record: { "DOI": "10.1016/j.nmni.2021.100915", "ISSN": [ "2052-2975" ], "URL": "http://dx.doi.org/10.1016/j.nmni.2021.100915", "alternative-id": [ "S2052297521000792" ], "article-number": "100915", "author": [ { "affiliation": [], "family": "Cadegiani", "given": "F.A.", "sequence": "first" }, { "ORCID": "http://orcid.org/0000-0002-8190-2289", "affiliation": [], "authenticated-orcid": false, "family": "Goren", "given": "A.", "sequence": "additional" }, { "affiliation": [], "family": "Wambier", "given": "C.G.", "sequence": "additional" }, { "affiliation": [], "family": "McCoy", "given": "J.", "sequence": "additional" } ], "container-title": "New Microbes and New Infections", "container-title-short": "New Microbes and New Infections", "content-domain": { "crossmark-restriction": false, "domain": [] }, "created": { "date-parts": [ [ 2021, 7, 7 ] ], "date-time": "2021-07-07T18:45:33Z", "timestamp": 1625683533000 }, "deposited": { "date-parts": [ [ 2021, 10, 8 ] ], "date-time": "2021-10-08T10:48:12Z", "timestamp": 1633690092000 }, "indexed": { "date-parts": [ [ 2024, 3, 28 ] ], "date-time": "2024-03-28T16:38:59Z", "timestamp": 1711643939685 }, "is-referenced-by-count": 16, "issued": { "date-parts": [ [ 2021, 9 ] ] }, "language": "en", "license": [ { "URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2021, 9, 1 ] ], "date-time": "2021-09-01T00:00:00Z", "timestamp": 1630454400000 } }, { "URL": "http://creativecommons.org/licenses/by-nc-nd/4.0/", "content-version": "vor", "delay-in-days": 0, "start": { "date-parts": [ [ 2021, 7, 2 ] ], "date-time": "2021-07-02T00:00:00Z", "timestamp": 1625184000000 } } ], "link": [ { "URL": "https://api.elsevier.com/content/article/PII:S2052297521000792?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://api.elsevier.com/content/article/PII:S2052297521000792?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining" } ], "member": "78", "original-title": [], "page": "100915", "prefix": "10.1016", "published": { "date-parts": [ [ 2021, 9 ] ] }, "published-print": { "date-parts": [ [ 2021, 9 ] ] }, "publisher": "Elsevier BV", "reference": [ { "article-title": "Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study", "author": "Zhou", "first-page": "30566", "issue": "20", "journal-title": "Lancet", "key": "10.1016/j.nmni.2021.100915_bib1", "volume": "S0140–6736", "year": "2020" }, { "DOI": "10.1371/journal.pone.0247461", "article-title": "Population risk factors for severe disease and mortality in COVID-19: a global systematic review and meta-analysis", "author": "Booth", "doi-asserted-by": "crossref", "issue": "3", "journal-title": "PLoS One", "key": "10.1016/j.nmni.2021.100915_bib2", "volume": "16", "year": "2021" }, { "DOI": "10.1186/s12902-020-00626-0", "article-title": "Repurposing existing drugs for COVID-19: an endocrinology perspective", "author": "Cadegiani", "doi-asserted-by": "crossref", "first-page": "149", "issue": "1", "journal-title": "BMC Endocr Disord", "key": "10.1016/j.nmni.2021.100915_bib3", "volume": "20", "year": "2020" }, { "DOI": "10.1002/der2.50", "article-title": "COVID-19, androgens, and androgenic alopecia", "author": "Gustavo Wambier", "doi-asserted-by": "crossref", "first-page": "146", "journal-title": "Dermatol Rev", "key": "10.1016/j.nmni.2021.100915_bib4a", "volume": "2", "year": "2021" }, { "DOI": "10.1111/jdv.16956", "article-title": "Androgen receptor genetic variant predicts COVID-19 disease severity: a prospective longitudinal study of hospitalized COVID-19 male patients", "author": "McCoy", "doi-asserted-by": "crossref", "first-page": "e15", "issue": "1", "journal-title": "J Eur Acad Dermatol Venereol", "key": "10.1016/j.nmni.2021.100915_bib4b", "volume": "35", "year": "2021" }, { "DOI": "10.1136/bcr-2021-241572", "article-title": "Potential risk for developing severe COVID-19 disease among anabolic steroid users", "author": "Cadegiani", "doi-asserted-by": "crossref", "issue": "2", "journal-title": "BMJ Case Rep", "key": "10.1016/j.nmni.2021.100915_bib5", "volume": "14", "year": "2021" }, { "DOI": "10.1111/jdv.17004", "article-title": "Clinical symptoms of hyperandrogenic women diagnosed with COVID-19", "author": "Cadegiani", "doi-asserted-by": "crossref", "first-page": "e101", "issue": "2", "journal-title": "J Eur Acad Dermatol Venereol", "key": "10.1016/j.nmni.2021.100915_bib6", "volume": "35", "year": "2021" }, { "DOI": "10.1530/EJE-20-1163", "article-title": "Increased COVID-19 infections in women with polycystic ovary syndrome: a population-based study", "author": "Subramanian", "doi-asserted-by": "crossref", "first-page": "637", "issue": "5", "journal-title": "Eur J Endocrinol", "key": "10.1016/j.nmni.2021.100915_bib7", "volume": "184", "year": "2021" }, { "article-title": "Hydroxychloroquine: a comprehensive review and its controversial role in coronavirus disease 2019", "author": "Bansal", "first-page": "1", "journal-title": "Ann Med", "key": "10.1016/j.nmni.2021.100915_bib8", "year": "2020" }, { "DOI": "10.1038/s41467-020-19056-6", "article-title": "A pragmatic randomized controlled trial reports lack of efficacy of hydroxychloroquine on coronavirus disease 2019 viral kinetics", "author": "Lyngbakken", "doi-asserted-by": "crossref", "first-page": "5284", "issue": "1", "journal-title": "Nat Commun", "key": "10.1016/j.nmni.2021.100915_bib9", "volume": "11", "year": "2020" }, { "DOI": "10.1080/20477724.2021.1936818", "article-title": "Hydroxychloroquine and mortality in COVID-19 patients: a systematic review and a meta-analysis of observational studies and randomized controlled trials", "author": "Di Castelnuovo", "doi-asserted-by": "crossref", "first-page": "1", "journal-title": "Pathog Glob Health", "key": "10.1016/j.nmni.2021.100915_bib10", "year": "2021" }, { "article-title": "Prophylaxis against covid-19: living systematic review and network meta-analysis", "author": "Bartoszko", "first-page": "373", "journal-title": "BMJ", "key": "10.1016/j.nmni.2021.100915_bib11", "year": "2021" }, { "DOI": "10.1093/jtm/taab005", "article-title": "From hydroxychloroquine to ivermectin: what are the anti-viral properties of anti-parasitic drugs to combat SARS-CoV-2?", "author": "Rakedzon", "doi-asserted-by": "crossref", "first-page": "taab005", "issue": "2", "journal-title": "J Travel Med", "key": "10.1016/j.nmni.2021.100915_bib13", "volume": "28", "year": "2021" }, { "article-title": "Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment", "author": "Li", "journal-title": "J Cell Physiol", "key": "10.1016/j.nmni.2021.100915_bib14", "year": "2020" }, { "article-title": "Ivermectin as a broad-spectrum host-directed antiviral: the real deal? Cells", "author": "Jans", "first-page": "E2100", "issue": "9", "key": "10.1016/j.nmni.2021.100915_bib15", "volume": "9", "year": "2020" }, { "DOI": "10.1093/cid/ciab591", "article-title": "Ivermectin for the treatment of COVID-19: a systematic review and meta-analysis of randomized controlled trials", "author": "Roman", "doi-asserted-by": "crossref", "first-page": "ciab591", "journal-title": "Clin Infect Dis", "key": "10.1016/j.nmni.2021.100915_bib16", "year": "2021" }, { "DOI": "10.1097/MJT.0000000000001402", "article-title": "Ivermectin for prevention and treatment of COVID-19 infection: a systematic review, meta-analysis, and trial sequential analysis to inform clinical guidelines", "author": "Bryant", "doi-asserted-by": "crossref", "journal-title": "Am J Ther", "key": "10.1016/j.nmni.2021.100915_bib17", "year": "2021" }, { "DOI": "10.1177/10600280211028242", "article-title": "Interventions in an ambulatory setting to prevent progression to severe disease in patients with COVID-19: a systematic review", "author": "O Murchu", "doi-asserted-by": "crossref", "journal-title": "Ann Pharmacother", "key": "10.1016/j.nmni.2021.100915_bib18", "year": "2021" }, { "DOI": "10.1016/j.virol.2018.03.023", "article-title": "Inhibition of vaccinia virus replication by nitazoxanide", "author": "Hickson", "doi-asserted-by": "crossref", "first-page": "398", "journal-title": "Virology", "key": "10.1016/j.nmni.2021.100915_bib19", "volume": "518", "year": "2018" }, { "article-title": "Nitazoxanide and JIB-04 have broad-spectrum antiviral activity and inhibit SARS-CoV-2 replication in cell culture and coronavirus pathogenesis in a pig model", "author": "Son", "journal-title": "bioRxiv", "key": "10.1016/j.nmni.2021.100915_bib20", "year": "2020" }, { "DOI": "10.1183/13993003.03725-2020", "article-title": "Early use of nitazoxanide in mild Covid-19 disease: randomised, placebo-controlled trial", "author": "Rocco", "doi-asserted-by": "crossref", "first-page": "2003725", "journal-title": "Eur Respir J", "key": "10.1016/j.nmni.2021.100915_bib21", "year": "2021" }, { "DOI": "10.1186/s43141-020-00055-5", "article-title": "Drug repurposing of nitazoxanide: can it be an effective therapy for COVID-19?", "author": "Mahmoud", "doi-asserted-by": "crossref", "first-page": "35", "issue": "1", "journal-title": "J Genet Eng Biotechnol", "key": "10.1016/j.nmni.2021.100915_bib22", "volume": "18", "year": "2020" }, { "DOI": "10.1038/s41467-021-22446-z", "article-title": "Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials", "author": "Axfors", "doi-asserted-by": "crossref", "first-page": "2349", "issue": "1", "journal-title": "Nat Commun", "key": "10.1016/j.nmni.2021.100915_bib23", "volume": "12", "year": "2021" }, { "DOI": "10.1016/j.eclinm.2021.100981", "article-title": "Nitazoxanide superiority to placebo to treat moderate COVID-19 A Pilot prove of concept randomized double-blind clinical trial", "author": "Blum", "doi-asserted-by": "crossref", "journal-title": "EClinicalMedicine", "key": "10.1016/j.nmni.2021.100915_bib24", "year": "2021" }, { "DOI": "10.1152/ajpendo.00136.2020", "article-title": "Can spironolactone be used to prevent COVID-19-induced acute respiratory distress syndrome in patients with hypertension?", "author": "Cadegiani", "doi-asserted-by": "crossref", "first-page": "E587", "issue": "5", "journal-title": "Am J Physiol Endocrinol Metab", "key": "10.1016/j.nmni.2021.100915_bib25", "volume": "318", "year": "2020" }, { "DOI": "10.1016/j.mehy.2020.110112", "article-title": "Spironolactone may provide protection from SARS-CoV-2: targeting androgens, angiotensin converting enzyme 2 (ACE2), and renin-angiotensin-aldosterone system (RAAS)", "author": "Cadegiani", "doi-asserted-by": "crossref", "first-page": "110112", "journal-title": "Med Hypotheses", "key": "10.1016/j.nmni.2021.100915_bib26", "volume": "143", "year": "2020" }, { "DOI": "10.3389/fmed.2020.00453", "article-title": "Spironolactone: an anti-androgenic and anti-hypertensive drug that may provide protection against the novel coronavirus (SARS-CoV-2) induced acute respiratory distress syndrome (ARDS) in COVID-19", "author": "Cadegiani", "doi-asserted-by": "crossref", "first-page": "453", "journal-title": "Front Med (Lausanne)", "key": "10.1016/j.nmni.2021.100915_bib27", "volume": "7", "year": "2020" }, { "DOI": "10.1111/jdv.17021", "article-title": "5-alpha-reductase inhibitors are associated with reduced frequency of COVID-19 symptoms in males with androgenetic alopecia", "author": "McCoy", "doi-asserted-by": "crossref", "first-page": "e243", "issue": "4", "journal-title": "J Eur Acad Dermatol Venereol", "key": "10.1016/j.nmni.2021.100915_bib28", "volume": "35", "year": "2021" }, { "DOI": "10.1111/jdv.16953", "article-title": "Anti-androgens may protect against severe COVID-19 outcomes: results from a prospective cohort study of 77 hospitalized men", "author": "Goren", "doi-asserted-by": "crossref", "first-page": "e13", "issue": "1", "journal-title": "J Eur Acad Dermatol Venereol", "key": "10.1016/j.nmni.2021.100915_bib29", "volume": "35", "year": "2021" }, { "author": "Lazzeri", "journal-title": "medRxiv", "key": "10.1016/j.nmni.2021.100915_bib30", "year": "2020" }, { "article-title": "Early antiandrogen therapy with dutasteride reduces viral shedding, inflammatory responses, and time-to-remission in males with COVID-19: a randomized, double-blind, placebo-controlled interventional trial (EAT-DUTA AndroCoV trial - biochemical)", "author": "Cadegiani", "issue": "2", "journal-title": "Cureus", "key": "10.1016/j.nmni.2021.100915_bib31", "volume": "13", "year": "2021" }, { "article-title": "Proxalutamide significantly accelerates viral clearance and reduces time to clinical remission in patients with mild to moderate COVID-19: results from a randomized, double-blinded, placebo-controlled trial", "author": "Cadegiani", "issue": "2", "journal-title": "Cureus", "key": "10.1016/j.nmni.2021.100915_bib32", "volume": "13", "year": "2021" }, { "author": "Cadegiani", "key": "10.1016/j.nmni.2021.100915_bib33" }, { "author": "Cadegiani", "key": "10.1016/j.nmni.2021.100915_bib34" }, { "author": "Cadegiani", "key": "10.1016/j.nmni.2021.100915_bib35" }, { "DOI": "10.1136/bmj.m1966", "article-title": "Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study", "author": "Petrilli", "doi-asserted-by": "crossref", "first-page": "m1966", "journal-title": "BMJ", "key": "10.1016/j.nmni.2021.100915_bib36", "volume": "369", "year": "2020" }, { "key": "10.1016/j.nmni.2021.100915_bib38", "series-title": "Report of the WHO-China Joint Mission on Coronavirus DIsease 2019 (COVID-2019)", "year": "2020" }, { "DOI": "10.1016/S1473-3099(20)30243-7", "article-title": "Estimates of the severity of coronavirus disease 2019: a model-based analysis", "author": "Verity", "doi-asserted-by": "crossref", "first-page": "669", "journal-title": "Lancet Infect Dis", "key": "10.1016/j.nmni.2021.100915_bib39", "volume": "20", "year": "2020" }, { "DOI": "10.1016/S0140-6736(20)30566-3", "article-title": "Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study", "author": "Zhou", "doi-asserted-by": "crossref", "first-page": "1054", "journal-title": "Lancet", "key": "10.1016/j.nmni.2021.100915_bib40", "volume": "395", "year": "2020" }, { "article-title": "Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy", "author": "Onder", "first-page": "1775", "journal-title": "JAMA", "key": "10.1016/j.nmni.2021.100915_bib41", "volume": "323", "year": "2020" }, { "DOI": "10.1001/jama.2020.4031", "article-title": "Critical care utilization for the COVID-19 outbreak in lombardy, Italy: early experience and forecast during an emergency response", "author": "Grasselli", "doi-asserted-by": "crossref", "first-page": "1545", "journal-title": "JAMA", "key": "10.1016/j.nmni.2021.100915_bib42", "volume": "323", "year": "2020" }, { "DOI": "10.1016/j.ijid.2020.09.1464", "article-title": "A systematic review and meta-analysis of published research data on COVID-19 infection-fatality rates", "author": "Meyerowitz-Katz", "doi-asserted-by": "crossref", "journal-title": "Int J Infect Dis", "key": "10.1016/j.nmni.2021.100915_bib43", "year": "2020" }, { "DOI": "10.1001/jama.2020.11787", "article-title": "Excess deaths from COVID-19 and other causes, march-april 2020", "author": "Woolf", "doi-asserted-by": "crossref", "first-page": "510", "journal-title": "JAMA", "key": "10.1016/j.nmni.2021.100915_bib44", "volume": "324", "year": "2020" }, { "DOI": "10.15585/mmwr.mm6924e2", "article-title": "Coronavirus disease 2019 case surveillance - United States, january 22-may 30, 2020", "author": "Stokes", "doi-asserted-by": "crossref", "first-page": "759", "journal-title": "MMWR Morb Mortal Wkly Rep", "key": "10.1016/j.nmni.2021.100915_bib45", "volume": "69", "year": "2020" }, { "DOI": "10.1093/cid/ciaa924", "article-title": "Association between male sex and outcomes of Coronavirus Disease 2019 (Covid-19) - a Danish nationwide, register553 based study", "author": "Kragholm", "doi-asserted-by": "crossref", "journal-title": "Clin Infect Dis", "key": "10.1016/j.nmni.2021.100915_bib46", "year": "2020" }, { "DOI": "10.1056/NEJMsa2011686", "article-title": "Hospitalization and mortality among black patients and white patients with covid-19", "author": "Price-Haywood", "doi-asserted-by": "crossref", "first-page": "2534", "journal-title": "N Engl J Med", "key": "10.1016/j.nmni.2021.100915_bib47", "volume": "382", "year": "2020" }, { "DOI": "10.15585/mmwr.mm6928e1", "article-title": "Characteristics of persons who died with COVID-19 — United States, february 12–may 18, 2020", "author": "Wortham", "doi-asserted-by": "crossref", "journal-title": "MMWR Morb Mortal Wkly Rep", "key": "10.1016/j.nmni.2021.100915_bib48", "year": "2020" }, { "DOI": "10.1016/S0140-6736(20)30183-5", "article-title": "Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China", "author": "Huang", "doi-asserted-by": "crossref", "first-page": "497", "journal-title": "Lancet", "key": "10.1016/j.nmni.2021.100915_bib49", "volume": "395", "year": "2020" }, { "DOI": "10.1016/S0140-6736(20)30211-7", "article-title": "Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study", "author": "Chen", "doi-asserted-by": "crossref", "first-page": "507", "journal-title": "Lancet", "key": "10.1016/j.nmni.2021.100915_bib50", "volume": "395", "year": "2020" }, { "DOI": "10.1056/NEJMc2010419", "article-title": "Clinical characteristics of covid-19 in New York city", "author": "Goyal", "doi-asserted-by": "crossref", "first-page": "2372", "journal-title": "N Engl J Med", "key": "10.1016/j.nmni.2021.100915_bib51", "volume": "382", "year": "2020" }, { "DOI": "10.1016/j.mayocp.2020.04.010", "article-title": "The 566 early natural history of SARS-CoV-2 infection: clinical observations from an urban, ambulatory COVID-19 clinic", "author": "Cohen", "doi-asserted-by": "crossref", "first-page": "1124", "journal-title": "Mayo Clin Proc", "key": "10.1016/j.nmni.2021.100915_bib52", "volume": "95", "year": "2020" }, { "DOI": "10.1001/jama.2020.1585", "article-title": "Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China", "author": "Wang", "doi-asserted-by": "crossref", "first-page": "1061", "journal-title": "JAMA", "key": "10.1016/j.nmni.2021.100915_bib53", "volume": "323", "year": "2020" }, { "DOI": "10.1001/jamainternmed.2020.0994", "article-title": "Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China", "author": "Wu", "doi-asserted-by": "crossref", "first-page": "934", "issue": "7", "journal-title": "JAMA Intern Med", "key": "10.1016/j.nmni.2021.100915_bib54", "volume": "180", "year": "2020" }, { "DOI": "10.1001/jama.2020.3204", "article-title": "Singapore 2019 novel coronavirus outbreak research team. Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore", "author": "Young", "doi-asserted-by": "crossref", "first-page": "1488", "issue": "15", "journal-title": "JAMA", "key": "10.1016/j.nmni.2021.100915_bib56", "volume": "323", "year": "2020" }, { "DOI": "10.1016/j.cmi.2020.04.040", "article-title": "Clinical characteristics of asymptomatic and symptomatic patients with mild COVID-19", "author": "Kim", "doi-asserted-by": "crossref", "first-page": "948.e1", "issue": "7", "journal-title": "Clin Microbiol Infect", "key": "10.1016/j.nmni.2021.100915_bib57", "volume": "26", "year": "2020" }, { "DOI": "10.4103/sjmms.sjmms_853_20", "article-title": "Natural history and clinical course of symptomatic and asymptomatic COVID-19 patients in the Kingdom of Saudi arabia", "author": "Almubark", "doi-asserted-by": "crossref", "first-page": "118", "issue": "2", "journal-title": "Saudi J Med Med Sci", "key": "10.1016/j.nmni.2021.100915_bib58", "volume": "9", "year": "2021" }, { "DOI": "10.1016/j.jns.2020.117179", "article-title": "589 Post-COVID 19 Neurological Syndrome (PCNS); a novel syndrome with challenges for the global neurology community", "author": "Wijeratne", "doi-asserted-by": "crossref", "first-page": "117179", "journal-title": "J Neurol Sci", "key": "10.1016/j.nmni.2021.100915_bib59", "volume": "419", "year": "2020" }, { "DOI": "10.1016/j.imlet.2020.09.005", "article-title": "How NETosis could drive \"Post-COVID-19 syndrome\" among survivors", "author": "Sawadogo", "doi-asserted-by": "crossref", "first-page": "35", "journal-title": "Immunol Lett", "key": "10.1016/j.nmni.2021.100915_bib60", "volume": "228", "year": "2020" }, { "article-title": "Assessment and characterization of post-COVID-19 manifestations", "author": "Tolba", "journal-title": "Int J Clin Pract", "key": "10.1016/j.nmni.2021.100915_bib61", "year": "2020" }, { "DOI": "10.1016/j.ensci.2020.100276", "article-title": "Post COVID-19 syndrome associated with orthostatic cerebral hypoperfusion syndrome, small fiber neuropathy and benefit of immunotherapy: a case report", "author": "Novak", "doi-asserted-by": "crossref", "first-page": "100276", "journal-title": "eNeurologicalSci", "key": "10.1016/j.nmni.2021.100915_bib62", "volume": "21", "year": "2020" }, { "DOI": "10.1016/j.ijid.2020.09.016", "article-title": "Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome", "author": "Afrin", "doi-asserted-by": "crossref", "first-page": "327", "journal-title": "Int J Infect Dis", "key": "10.1016/j.nmni.2021.100915_bib63", "volume": "100", "year": "2020" }, { "DOI": "10.1093/qjmed/hcaa248", "article-title": "Post COVID Syndrome (PCS) and healthcare workers: who cares for the carers?", "author": "Donnelly", "doi-asserted-by": "crossref", "first-page": "611", "issue": "9", "journal-title": "QJM", "key": "10.1016/j.nmni.2021.100915_bib64", "volume": "113", "year": "2020" }, { "DOI": "10.1016/j.eclinm.2021.100899", "article-title": "Characteristics and predictors of acute and chronic post-COVID syndrome: a systematic review and meta-analysis", "author": "Iqbal", "doi-asserted-by": "crossref", "first-page": "100899", "journal-title": "EClinicalMedicine", "key": "10.1016/j.nmni.2021.100915_bib65", "volume": "36", "year": "2021" }, { "article-title": "Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: a systematic review and meta-analysis", "author": "Fernández-de-Las-Peñas", "first-page": "208", "issue": "21", "journal-title": "Eur J Intern Med", "key": "10.1016/j.nmni.2021.100915_bib66", "volume": "S0953–6205", "year": "2021" }, { "article-title": "Health-related quality of life issues, including symptoms, in patients with active COVID-19 or post COVID-19; a systematic literature review", "author": "Amdal", "first-page": "1", "journal-title": "Qual Life Res", "key": "10.1016/j.nmni.2021.100915_bib67", "year": "2021" }, { "DOI": "10.1016/j.cct.2013.09.003", "article-title": "The ethics of placebo-controlled trials: methodological justifications", "author": "Millum", "doi-asserted-by": "crossref", "first-page": "510", "issue": "2", "journal-title": "Contemp Clin Trial.", "key": "10.1016/j.nmni.2021.100915_bib68", "volume": "36", "year": "2013" }, { "article-title": "International ethical guidelines for biomedical research involving human subjects.Council for International Organizations of Medical Sciences", "first-page": "17", "issue": "182", "journal-title": "Bull Med Ethics", "key": "10.1016/j.nmni.2021.100915_bib69", "year": "2002" }, { "DOI": "10.1073/pnas.2106535118", "article-title": "Characterization of a new SARS-CoV-2 variant that emerged in Brazil", "author": "Imai", "doi-asserted-by": "crossref", "issue": "27", "journal-title": "Proc Natl Acad Sci U S A", "key": "10.1016/j.nmni.2021.100915_bib70", "volume": "118", "year": "2021" } ], "reference-count": 68, "references-count": 68, "relation": { "has-preprint": [ { "asserted-by": "object", "id": "10.1101/2020.10.31.20223883", "id-type": "doi" } ] }, "resource": { "primary": { "URL": "https://linkinghub.elsevier.com/retrieve/pii/S2052297521000792" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [ "Infectious Diseases", "Microbiology" ], "subtitle": [], "title": "Early COVID-19 therapy with azithromycin plus nitazoxanide, ivermectin or hydroxychloroquine in outpatient settings significantly improved COVID-19 outcomes compared to known outcomes in untreated patients", "type": "journal-article", "volume": "43" }